Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.

Jan Jacques Michiels, Alain Gadisseur, Marc van der Planken, Wilfried Schroyens, Marianne De Maeseneer, Jan T Hermsen, Paul H Trienekens, Henk Hoogsteden, Peter M T Pattynama
{"title":"Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.","authors":"Jan Jacques Michiels,&nbsp;Alain Gadisseur,&nbsp;Marc van der Planken,&nbsp;Wilfried Schroyens,&nbsp;Marianne De Maeseneer,&nbsp;Jan T Hermsen,&nbsp;Paul H Trienekens,&nbsp;Henk Hoogsteden,&nbsp;Peter M T Pattynama","doi":"10.1055/s-2005-922480","DOIUrl":null,"url":null,"abstract":"<p><p>The requirement for a safe diagnostic strategy should be based on an overall posttest incidence of venous thromboembolism (VTE) of less than 1% during 3-month follow-up. The negative predictive value (NPV) during 3 months of follow-up is 98.1 to 99% after a normal venogram, 97 to 98% after a normal compression ultrasonography (CUS), and > 99% after serial CUS testing. Serial CUS testing is safe but 100 CUS must be repeated to find one or two CUS positive for deep vein thrombosis (DVT), which is not cost-effective and indicates the need to improve the diagnostic workup of DVT by the use of clinical score assessment and D-dimer testing. The NPV varies from 97.6 to 99.4% for low clinical score followed by a negative SimpiRED test, indicating the need for a first CUS. The NPV is 98.4 to 99.3% for a normal rapid enzyme-linked immunosorbent assay (ELISA) VIDAS D-dimer test result (< 500 ng/mL) irrespective of clinical score. The NPV is more than 99% for a negative CUS followed by either a negative SimpiRED test or an ELISA VIDAS test result of < 1000 ng/mL without the need to repeat a second CUS within 1 week. The sequential use of a sensitive, rapid ELISA D-dimer and clinical score assessment will safely reduce the need for CUS testing by 40 to 60%. Large prospective outcome studies demonstrate that with one negative examination with complete duplex color ultrasonography (CCUS) of the proximal and distal veins of the affected leg with suspected DVT, it is safe to withhold anticoagulant treatment, with a negative predictive value of 99.5%. This may indicates that CCUS is equal to serial CUS or the combined use of clinical score, D-dimer testing, and CUS. Pulmonary angiography is the gold standard for segmental pulmonary embolism (PE) but not for subsegmental PE. A normal perfusion lung scan and a normal rapid ELISA VIDAS D-dimer test safely excludes PE. Helical spiral computed tomography (CT) detects all clinically relevant PE and a large number of alternative diagnoses in symptomatic patients with suspected PE and can replace both the ventilation perfusion scan and pulmonary angiography to safely rule in PE and to rule out PE with an NPV of > 99%. The combination of clinical assessment, a rapid ELISA VIDAS D-dimer, followed by CUS will reduce the need for helical spiral CT by 40 to 50%.</p>","PeriodicalId":87139,"journal":{"name":"Seminars in vascular medicine","volume":"5 4","pages":"351-64"},"PeriodicalIF":0.0000,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2005-922480","citationCount":"25","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in vascular medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-2005-922480","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 25

Abstract

The requirement for a safe diagnostic strategy should be based on an overall posttest incidence of venous thromboembolism (VTE) of less than 1% during 3-month follow-up. The negative predictive value (NPV) during 3 months of follow-up is 98.1 to 99% after a normal venogram, 97 to 98% after a normal compression ultrasonography (CUS), and > 99% after serial CUS testing. Serial CUS testing is safe but 100 CUS must be repeated to find one or two CUS positive for deep vein thrombosis (DVT), which is not cost-effective and indicates the need to improve the diagnostic workup of DVT by the use of clinical score assessment and D-dimer testing. The NPV varies from 97.6 to 99.4% for low clinical score followed by a negative SimpiRED test, indicating the need for a first CUS. The NPV is 98.4 to 99.3% for a normal rapid enzyme-linked immunosorbent assay (ELISA) VIDAS D-dimer test result (< 500 ng/mL) irrespective of clinical score. The NPV is more than 99% for a negative CUS followed by either a negative SimpiRED test or an ELISA VIDAS test result of < 1000 ng/mL without the need to repeat a second CUS within 1 week. The sequential use of a sensitive, rapid ELISA D-dimer and clinical score assessment will safely reduce the need for CUS testing by 40 to 60%. Large prospective outcome studies demonstrate that with one negative examination with complete duplex color ultrasonography (CCUS) of the proximal and distal veins of the affected leg with suspected DVT, it is safe to withhold anticoagulant treatment, with a negative predictive value of 99.5%. This may indicates that CCUS is equal to serial CUS or the combined use of clinical score, D-dimer testing, and CUS. Pulmonary angiography is the gold standard for segmental pulmonary embolism (PE) but not for subsegmental PE. A normal perfusion lung scan and a normal rapid ELISA VIDAS D-dimer test safely excludes PE. Helical spiral computed tomography (CT) detects all clinically relevant PE and a large number of alternative diagnoses in symptomatic patients with suspected PE and can replace both the ventilation perfusion scan and pulmonary angiography to safely rule in PE and to rule out PE with an NPV of > 99%. The combination of clinical assessment, a rapid ELISA VIDAS D-dimer, followed by CUS will reduce the need for helical spiral CT by 40 to 50%.

通过顺序使用临床评分筛查疑似DVT或PE门诊患者的深静脉血栓形成和肺栓塞:一种敏感的定量d -二聚体测试和无创诊断工具。
对安全诊断策略的要求应基于3个月随访期间静脉血栓栓塞(VTE)的总体检测后发生率小于1%。随访3个月,静脉造影正常后阴性预测值(NPV)为98.1 ~ 99%,超声压缩检查正常后阴性预测值(NPV)为97 ~ 98%,连续超声压缩检查阴性预测值> 99%。连续进行CUS检测是安全的,但必须重复100次CUS才能发现1例或2例深静脉血栓形成(DVT)阳性,这是不符合成本效益的,需要通过临床评分评估和d -二聚体检测来改进DVT的诊断工作。对于临床评分低且simplired测试阴性的患者,NPV从97.6到99.4%不等,表明需要进行第一次CUS。无论临床评分如何,正常快速酶联免疫吸附试验(ELISA) VIDAS d -二聚体检测结果(< 500 ng/mL)的NPV为98.4%至99.3%。在1周内不需要重复第2次CUS,同时进行SimpiRED试验阴性或ELISA VIDAS试验< 1000 ng/mL的阴性CUS, NPV大于99%。连续使用灵敏、快速的ELISA d -二聚体和临床评分评估将安全地减少40 - 60%的CUS检测需求。大型前瞻性结果研究表明,怀疑深静脉血栓的患腿近端和远端静脉经一次全双彩超(CCUS)阴性检查后,可以安全地停止抗凝治疗,阴性预测值为99.5%。这可能表明CCUS等于连续CUS或联合使用临床评分、d -二聚体检测和CUS。肺血管造影是诊断节段性肺栓塞(PE)的金标准,但不是亚节段性肺栓塞的金标准。正常的肺灌注扫描和正常的快速ELISA VIDAS d -二聚体测试可以安全地排除PE。螺旋计算机断层扫描(CT)可在有症状的疑似PE患者中检测出所有临床相关的PE和大量替代诊断,并可替代通气灌注扫描和肺血管造影,安全地诊断PE并排除NPV > 99%的PE。结合临床评估,快速ELISA VIDAS d -二聚体,然后进行CUS,将减少40 - 50%的螺旋CT需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信